The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Brentuximab vedotin with chemotherapy in adolescents and young adults (AYAs) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 Echelon-1 study.
 
Howland E. Crosswell
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; Gilead Sciences; KIYATEC; Pfizer; Seagen
Consulting or Advisory Role - Daiichi Sankyo; servier
Speakers' Bureau - SERVIER
Patents, Royalties, Other Intellectual Property - KIYATEC
 
Ann S. LaCasce
Consulting or Advisory Role - Bristol-Myers Squibb; Forty Seven; Humanigen; Seagen
Speakers' Bureau - Research to Practice
Research Funding - Celgene (Inst); Forty Seven (Inst); Sanofi (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Up to Date royalties
 
Nancy L. Bartlett
Consulting or Advisory Role - Acerta Pharma; ADC Therapeutics; BTG; Roche/Genentech; Seagen
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
David J. Straus
Consulting or Advisory Role - Seagen; Takeda
 
Kerry J. Savage
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Kyowa; Merck; Novartis; Novartis; Novartis Canada Pharmaceuticals Inc; Seagen
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Merck; Seagen; Servier
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Seagen
(OPTIONAL) Uncompensated Relationships - Beigene
 
Pier Luigi Zinzani
Honoraria - Abbvie; EUSA Pharma; Merck; Roche; Takeda
Consulting or Advisory Role - Abbvie; EUSA Pharma; Merck; Roche; Takeda
Speakers' Bureau - EUSA Pharma; Gilead Sciences; Merck; Novartis; Takeda
 
Graham P. Collins
Honoraria - ADC Therapeutics; BeiGene; Celleron Therapeutics; Daiichi Sankyo; Gilead Sciences; Incyte; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - ADC Therapeutics; beigene; Celgene; Celleron Therapeutics; Daiichi Sankyo; Incyte; MSD; Pfizer; Roche; Takeda
Speakers' Bureau - Gilead Sciences; Novartis; Roche; Takeda
Research Funding - Amgen (Inst); BMS (Inst); Celgene (Inst); Celleron Therapeutics (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Roche; Takeda
 
Michelle A. Fanale
Employment - Seagen
Stock and Other Ownership Interests - Seagen
Honoraria - Bristol-Myers Squibb; Plexus; Research to Practice; Seagen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Seagen; Spectrum Pharmaceuticals
Research Funding - ADC Therapeutics; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; MedImmune; Merck; Millennium; Molecular Templates; Novartis; Pharmacyclics; Seagen; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Plexus; Research to Practice; Seagen; Spectrum Pharmaceuticals; Takeda
 
Keenan Fenton
Employment - Seagen
Stock and Other Ownership Interests - Seagen
Travel, Accommodations, Expenses - Seagen
 
Cassie Dong
Stock and Other Ownership Interests - Seagen; Takeda
 
Harry H. Miao
Employment - Takeda
Stock and Other Ownership Interests - Takeda; Takeda
 
Andrew Grigg
Honoraria - MSD; Roche
Consulting or Advisory Role - Janssen; MSD Oncology; Novartis